Infosys has invested an undisclosed amount in Aerchain, a Bengaluru-based AI-first procurement platform, through its innovation fund. The move aims to boost the IT giant's capabilities in autonomous supply chain workflows. While Aerchain remains a private startup, the investment highlights Infosys' ongoing strategy to integrate next-generation AI tools into its enterprise service offerings for global clients.
Infosys has expanded its artificial intelligence portfolio by taking a stake in Aerchain, a Bengaluru-based startup specializing in autonomous corporate procurement. The company announced the investment on August 27, 2026, through its internal investment arm, the Infosys Innovation Fund.
Aerchain develops software that uses multi-AI agent frameworks to manage complex procurement tasks, such as sourcing and supply chain automation. By backing this technology, Infosys aims to integrate these advanced automation capabilities into the services it provides to large global enterprises. This is a strategic effort to offer clients more efficient, data-driven tools to manage their supply chains.
A Strategic Push into Agentic AI
For Infosys, this investment is not just about financial returns. It is part of a broader strategy to stay ahead in the rapidly evolving enterprise AI market. Large IT services companies are increasingly looking to move beyond simple automation toward "agentic AI," where software can perform complex tasks with minimal human intervention. By partnering with or investing in specialized startups like Aerchain, Infosys can offer these cutting-edge capabilities to its massive client base, potentially creating new revenue streams.
Aerchain is a relatively young company, founded in 2019. It previously secured $13 million in funding in March 2026, a round that included participation from investors like Pavestone VC and IndiaMART. As a private company, Aerchain does not have publicly traded shares or exchange filings, meaning the financial terms of the Infosys deal remain undisclosed.
The Growth Strategy and Risks
The Infosys Innovation Fund, which operates with a $500 million mandate, has been highly active in recent months. The fund has also backed other specialized technology firms, including NinjaTech AI, the Swiss biotech company Indivi, and the venture capital group Team8. This pattern shows that Infosys is actively building a diversified portfolio of high-growth technology assets.
However, there are risks for investors to keep in mind. Investing in early-stage startups is inherently uncertain. The technology may not scale as expected, or it could struggle to find widespread adoption among large enterprises that rely on established legacy ERP systems from major global players. Additionally, integrating a startup’s specialized software into the complex environments of global corporate clients can be difficult and time-consuming. Success will depend on whether Aerchain’s AI agents can deliver measurable cost savings and efficiency gains for clients in a competitive market.
Investors may monitor Infosys' future earnings calls and management commentary for updates on the adoption rates of these new AI tools and how they are impacting the company's service offerings.